Iraq vs Sur: Previously treated cases tested for RR-/MDR-TB
Iraq
100.0%
in 2024
Sur
62.0%
in 2024
Iraq rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Iraq
- Sur
How they compare
Iraq currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Iraq's figure about 1.6 times Sur's.
The two have swapped places 7 times across 16 shared years of data; in 2008 it was Sur ahead.
Iraq ranks 1st and Sur ranks 1st of 180 countries.
Iraq has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.5% | 21.5% | 2.0% | Iraq |
| 2010s | 63.3% | 53.0% | 10.3% | Iraq |
| 2020s | 97.6% | 78.4% | 19.2% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Iraq or Sur?
- Iraq, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Iraq and Sur?
- 38.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Sur?
- 16 years are reported by both, from 2008 to 2024.
- How do Iraq and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Iraq ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.